RNS Number : 8323Y
Oncimmune Holdings PLC
20 May 2016
|
For filings with the FCA include the annex
|
|
|
For filings with issuer exclude the annex
|
|
|
|
|
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARESi
|
|
|
|
|
1. Identity of the issuer or the underlying issuer
of existing shares to which voting rights are
attached: ii
|
Oncimmune Holdings plc
|
|
2 Reason for the notification (please tick the appropriate box
or boxes):
|
|
An acquisition or disposal of voting rights
|
√
|
|
An acquisition or disposal of qualifying financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached
|
|
|
An acquisition or disposal of instruments with similar economic effect to qualifying
financial instruments
|
|
|
An event changing the breakdown of voting rights
|
|
|
Other (please specify):
|
|
|
|
3. Full name of person(s) subject to the
notification obligation: iii
|
Aviva plc & its subsidiaries
|
|
4. Full name of shareholder(s)
(if different from 3.):iv
|
Registered Holder:
BNY Norwich Union Nominees Limited 119,273*
Chase (GA Group) Nominees Limited 2,136,901*
*Denotes direct interest
|
|
5. Date of the transaction and date on
which the threshold is crossed or
reached: v
|
18 May 2016
|
|
6. Date on which issuer notified:
|
19 May 2016
|
|
7. Threshold(s) that is/are crossed or
reached: vi, vii
|
Nil Held to 4% Change at Direct Interest Level
|
|
|
|
|
|
|
|
8. Notified details:
|
|
A: Voting rights attached to shares viii,
ix
|
|
Class/type of
shares
if possible using
the ISIN CODE
|
Situation previous
to the triggering
transaction
|
Resulting situation after the triggering transaction
|
|
Number
of
Shares
|
Number
of
Voting
Rights
|
Number
of shares
|
Number of voting
rights
|
% of voting rights x
|
|
Direct
|
Direct xi
|
Indirect xii
|
Direct
|
Indirect
|
|
Ordinary Shares
GB00BYQ94H38
|
Nil Held
|
Nil Held
|
2,256,174
|
2,256,174
|
Not disclosable
|
4.42%
|
Not disclosable
|
|
|
|
|
|
B: Qualifying Financial Instruments
|
|
Resulting situation after the triggering transaction
|
|
Type of financial
instrument
|
Expiration
date xiii
|
Exercise/
Conversion Period xiv
|
Number of voting
rights that may be
acquired if the
instrument is
exercised/ converted.
|
% of voting
rights
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
C: Financial Instruments with similar economic effect to Qualifying Financial
Instruments xv, xvi
|
|
Resulting situation after the triggering transaction
|
|
Type of financial
instrument
|
Exercise price
|
Expiration date xvii
|
Exercise/
Conversion period xviii
|
Number of voting rights instrument refers to
|
% of voting rights xix, xx
|
|
|
|
|
|
|
Nominal
|
Delta
|
|
|
|
|
Total (A+B+C)
|
|
Number of voting rights
|
Percentage of voting rights
|
|
2,256,174
|
4.42%
|
|
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable: xxi
|
|
The voting rights are managed and controlled by Aviva Investors Global
Services Limited, with the following chains of controlled undertakings:-
Aviva Investors Global Services Limited:
· Aviva plc (Parent
Company)
· Aviva Group Holdings Limited
(wholly owned subsidiary of Aviva plc)
· Aviva Investors Holdings Limited
(wholly owned subsidiary of Aviva Group Holdings Limited)
· Aviva Investors Global Services
Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)
|
|
Proxy Voting:
|
|
10. Name of the proxy holder:
|
See Section 4
|
|
11. Number of voting rights proxy holder will cease
to hold:
|
|
|
12. Date on which proxy holder will cease to hold
voting rights:
|
|
|
13. Additional information:
|
Figures are based on the total number of voting rights of
51,024,404 shares, as per the Company's Admission to Trading on the London Stock Exchange
Announcement of 18 May 2015.
|
|
14. Contact name:
|
Neil Whittaker, Aviva plc
|
|
15. Contact telephone number:
|
01603 684420
|
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUROVRNKAVURR